Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetics just got SEXY: Sequences encoding XY.

Roy D Sleator1

  • 1Department of Biological Sciences; Cork Institute of Technology; Cork, Ireland.

Bioengineered
|May 23, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Science must be seen as a viable profession for the many, not the few.

Nature·2026
Same author

The role of Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: Advancing clinical applications.

eNeurologicalSci·2025
Same author

Prions: structure, function, evolution, and disease.

Archives of microbiology·2024
Same author

Solving the protein folding problem….

FEBS letters·2024
Same author

Genotypic and phenotypic characterisation of asymptomatic bacteriuria (ABU) isolates displaying bacterial interference against multi-drug resistant uropathogenic E. Coli.

Archives of microbiology·2024
Same author

COVID-19: did the masks work?

Future microbiology·2024
Same journal

Statement of Retraction: MicroRNA miR-331-3p suppresses osteosarcoma progression via the Bcl-2/Bax and Wnt/β-Catenin signaling pathways and the epithelial-mesenchymal transition by targeting N-acetylglucosaminyltransferase I (MGAT1).

Bioengineered·2026
Same journal

Statement of Retraction: Easy efficient HDR-based targeted knock-in in <i>Saccharomyces cerevisiae</i> genome using CRISPR-Cas9 system.

Bioengineered·2026
Same journal

Statement of Retraction: Geniposide promotes splenic Treg differentiation to alleviate colonic inflammation and intestinal barrier injury in ulcerative colitis mice.

Bioengineered·2026
Same journal

Statement of Retraction: Circular RNA hsa_circ_0000437 may be used as a new indicator for the diagnosis and prognosis of hepatocellular carcinoma.

Bioengineered·2026
Same journal

Statement of Retraction: The role of autophagy-related proteins in the pathogenesis of neuromyelitis optica spectrum disorders.

Bioengineered·2026
Same journal

Statement of Retraction: Long non-coding RNA lincRNA-erythroid prosurvival attenuates inflammation by enhancing myosin heavy chain 6 stability through recruitment of heterogeneous nuclear ribonucleoprotein L in myocardial infarction.

Bioengineered·2026
See all related articles

A novel semi-synthetic organism expands the genetic alphabet, opening new frontiers in synthetic biology. This breakthrough enables unprecedented control over biological systems and genetic information.

Area of Science:

  • Synthetic biology
  • Molecular biology
  • Genetics

Background:

  • The development of semi-synthetic organisms represents a significant advancement in biotechnology.
  • Traditional genetic systems rely on a limited set of DNA bases.

Discussion:

  • This study introduces a semi-synthetic organism engineered with an expanded genetic alphabet.
  • The extended alphabet allows for the encoding of novel information and functionalities.

Key Insights:

  • The creation of a semi-synthetic organism with an extended genetic alphabet is a landmark achievement.
  • This organism demonstrates the potential for novel biological designs and applications.

Outlook:

  • This work paves the way for a new era in synthetic biology, enabling more complex and precise biological engineering.

Related Experiment Videos

  • Future research may focus on further expanding the genetic alphabet and exploring its applications in medicine and materials science.